Literature DB >> 18471110

The discovery and development of the triptans, a major therapeutic breakthrough.

Patrick P A Humphrey1.   

Abstract

The drug discovery programs that led to the development of the triptans were determined by the membership of the American Headache Society to be the most important breakthrough in headache medicine in the last 50 years. Dr. Humphrey, who spearheaded the drug discovery, recounts the pioneering work that took place and examines its therapeutic impact.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18471110     DOI: 10.1111/j.1526-4610.2008.01097.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  14 in total

Review 1.  Drug interactions with triptans : which are clinically significant?

Authors:  Paul E Rolan
Journal:  CNS Drugs       Date:  2012-11       Impact factor: 5.749

Review 2.  Capillary endothelial Na(+), K(+), ATPase transporter homeostasis and a new theory for migraine pathophysiology.

Authors:  Michael G Harrington; Alfred N Fonteh; Xianghong Arakaki; Robert P Cowan; Laurel E Ecke; Hailey Foster; Andreas F Hühmer; Roger G Biringer
Journal:  Headache       Date:  2009-10-21       Impact factor: 5.887

Review 3.  Structure and function of serotonin G protein-coupled receptors.

Authors:  John D McCorvy; Bryan L Roth
Journal:  Pharmacol Ther       Date:  2015-01-17       Impact factor: 12.310

4.  Sir David Jack: an extraordinary drug discoverer and developer.

Authors:  Clive Page; Patrick Humphrey
Journal:  Br J Clin Pharmacol       Date:  2013-05       Impact factor: 4.335

Review 5.  Lost but making progress--Where will new analgesic drugs come from?

Authors:  David Borsook; Richard Hargreaves; Chas Bountra; Frank Porreca
Journal:  Sci Transl Med       Date:  2014-08-13       Impact factor: 17.956

6.  Insights Into the Molecular Mechanism of Triptan Transport by P-glycoprotein.

Authors:  Laura A Wilt; Diana Nguyen; Arthur G Roberts
Journal:  J Pharm Sci       Date:  2017-03-07       Impact factor: 3.534

7.  Triptans: where things stand.

Authors:  Alan K Cole; Michael J Marmura
Journal:  Curr Treat Options Neurol       Date:  2010-09       Impact factor: 3.598

8.  Cranioselectivity of sumatriptan revisited: pronounced contractions to sumatriptan in small human isolated coronary artery.

Authors:  Kayi Y Chan; Sieneke Labruijere; Martha B Ramírez Rosas; René de Vries; Ingrid M Garrelds; Alexander H J Danser; Carlos M Villalón; Antoon van den Bogaerdt; Clemens Dirven; Antoinette MaassenVanDenBrink
Journal:  CNS Drugs       Date:  2014-03       Impact factor: 5.749

9.  Triptan partition in model membranes.

Authors:  Irene Wood; Mónica Pickholz
Journal:  J Mol Model       Date:  2014-09-24       Impact factor: 1.810

Review 10.  Migraine pain: reflections against vasodilatation.

Authors:  Alessandro Panconesi; Maria Letizia Bartolozzi; Leonello Guidi
Journal:  J Headache Pain       Date:  2009-06-05       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.